Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027

フローサイトメトリーのグローバル市場予測(~2027):細胞ベース、ビーズベース

◆タイトル:Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027
◆商品コード:BT6015-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年8月29日
◆ページ数:319
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社の最新調査レポートによると、世界のフローサイトメトリー市場規模は、2022年47億ドルから2027年69億ドルまで年平均8.1%成長すると推定されます。当書は、フローサイトメトリーの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、技術別(細胞ベース、ビーズベース)分析、製品&サービス別(試薬&消耗品、機器、サービス、ソフトウェア、付属品)分析、用途別(研究用、臨床用、免疫不全疾患用、産業用)分析、エンドユーザー別(学術&研究機関、病院&臨床検査室、医薬品&バイオ医薬品会社)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、企業情報などについて総合的にまとめています。なお、当書に掲載されている企業情報には、Becton、Dickinson and Company (US)、Danaher Corporation (US)、Thermo Fisher Scientific, Inc. (US)、Luminex Corporation (US)、Agilent Technologies, Inc. (US)、Sony Group Corporation (Japan)、Bio-Rad Laboratories, Inc. (US)、Miltenyi Biotec GmbH (Germany)、Enzo Biochem, Inc. (US)、Sysmex Corporation (Japan)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のフローサイトメトリー市場規模:技術別
- 細胞ベースフローサイトメトリーの市場規模
- ビーズベースフローサイトメトリーの市場規模
・世界のフローサイトメトリー市場規模:製品&サービス別
- フローサイトメトリー用試薬&消耗品の市場規模
- フローサイトメトリー用機器の市場規模
- フローサイトメトリーサービスの市場規模
- フローサイトメトリーソフトウェアの市場規模
- フローサイトメトリー付属品の市場規模
・世界のフローサイトメトリー市場規模:用途別
- 研究用フローサイトメトリーの市場規模
- 臨床用フローサイトメトリーの市場規模
- 免疫不全疾患用フローサイトメトリーの市場規模
- 産業用フローサイトメトリーの市場規模
・世界のフローサイトメトリー市場規模:エンドユーザー別
- 学術&研究機関における市場規模
- 病院&臨床検査室における市場規模
- 医薬品&バイオ医薬品会社における市場規模
・世界のフローサイトメトリー市場規模:地域別
- 北米のフローサイトメトリー市場規模
- ヨーロッパのフローサイトメトリー市場規模
- アジア太平洋のフローサイトメトリー市場規模
- 中南米のフローサイトメトリー市場規模
- 中東・アフリカのフローサイトメトリー市場規模
・競争状況
・企業情報

“The global flow cytometry market is projected to reach USD 6.9 billion by 2027 from USD 4.7 billion in 2022, at a CAGR of 8.1% during the forecast period.”
Rising prevalence of HIV/AIDS, cancer & autoimmune diseases across the globe is increasing adoption of flow cytometry for diagnosis hence projecting the market growth. Additionally, launch of technologically advent product is furthermore likely to propel the market growth during the forecast period of 2022-2027.

“Instruments segment held a substantial share in the global flow cytometry market in 2021.”
Based on product & services, the market is segmented into reagents & consumables, instruments, services, software and accessories. The reagents & consumables segment held a dominant share in the market in 2021 and anticipated to continue dominance during the forecast period. Launch of new reagents & consumables in the market which are making research to grow at faster pace is likely to drive segmental growth. In November 2021, Bio-Rad Laboratories, Inc. (US), launched StarBright UltraViolet 400 Dye, fluorescent nanoparticles designed for use with a UV laser in flow cytometry applications.

“Research applications segment dominated the market in 2021.”
Based on end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. Strong focus of key market players in the clinical applications of flow cytometry is likely to project the segmental growth. For isnatnce, in October 2021, BD (Becton, Dickinson and Company)(US), in collaboration with Christian Medical College Vellore (India) launched its second Center of Excellence (CoE) in flow cytometry for clinical research in India.

“North America held dominant share in 2021.”
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the major share in the flow cytometry market. North America held dominant share owing to presence of key market players coupled with increased adoption of flow cytometry in research application in the region. Asia Pacific is expected to grow at faster pace due to increased research funding and adoption of flow cytometry in clinical applications.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Supply Side: 70.0%, Demand Side: 30.0%
• By Designation – Managers: 45.0%, CXOs & Directors:30.0%, Excecutives:25.0%
• By Region – North America: 20%, Europe: 10%, Asia Pacific: 55%, Latin America: 10%, and the Middle East and Africa: 5%

List of Companies Profiled in the Report
o Becton, Dickinson and Company (US)
o Danaher Corporation (US)
o Thermo Fisher Scientific, Inc. (US)
o Luminex Corporation (US)
o Agilent Technologies, Inc. (US)
o Sony Group Corporation (Japan)
o Bio-Rad Laboratories, Inc. (US)
o Miltenyi Biotec GmbH (Germany)
o Enzo Biochem, Inc. (US)
o Sysmex Corporation (Japan)
o bioMérieux S.A. (France)
o Cytonome/ST, LLC (US)
o Sartorius AG (Germany)
o Cytek Biosciences, Inc. (US)
o Union Biometrica, Inc. (US)
o Apogee Flow Systems Ltd. (UK)
o Stratedigm, Inc. (US)
o NanoCellect Biomedical, Inc. (US)
o On-chip Biotechnologies, Co., Ltd. (Japan)
o BennuBio Inc. (US)
o ORFLO Technologies (US)
o Bay Biosciences Co., Ltd. (Japan)
o BioLegend, Inc. (US)
o CytoBuoy B.V (Netherlands)

Research Coverage:
This report provides a detailed picture of the global flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments, such as technology, product & services, application, end user and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total flow cytometry market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the flow cytometry market. The report analyses the flow cytometry market by technology, product & services, application, end user and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various flow cytometry products across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the flow cytometry market.

【レポートの目次】

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.2.1 INCLUSIONS & EXCLUSIONS 44
1.3 STUDY SCOPE 44
1.3.1 MARKETS COVERED 44
1.3.2 YEARS CONSIDERED 45
1.4 CURRENCY CONSIDERED 45
1.5 LIMITATIONS 45
1.6 STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 48
2.1 RESEARCH DATA 48
FIGURE 1 RESEARCH DESIGN 48
2.1.1 SECONDARY DATA 49
2.1.2 PRIMARY DATA 50
FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 50
2.2 MARKET ESTIMATION METHODOLOGY 51
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 51
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 52
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION (2021) 52
2.3 DATA TRIANGULATION APPROACH 54
FIGURE 5 DATA TRIANGULATION METHODOLOGY 54
2.4 GROWTH FORECAST 55
2.5 LIMITATIONS 55
2.6 RISK ASSESSMENT 55
2.7 CAGR PROJECTIONS 56
2.7.1 SUPPLY-SIDE ANALYSIS 56
2.7.2 DEMAND-SIDE ANALYSIS 56
2.7.3 INSIGHTS FROM PRIMARY EXPERTS 57
3 EXECUTIVE SUMMARY 58
FIGURE 6 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 7 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 59
FIGURE 8 FLOW CYTOMETRY MARKET, BY END USER, 2021 59
FIGURE 9 GEOGRAPHICAL SNAPSHOT 60
4 PREMIUM INSIGHTS 61
4.1 FLOW CYTOMETRY MARKET OVERVIEW 61
FIGURE 10 INCREASING PREVALENCE OF AUTOIMMUNE DISEASES AND RISING ADVANCEMENTS IN FLOW CYTOMETRY TECHNIQUES DRIVE MARKET GROWTH 61
4.2 ASIA PACIFIC: FLOW CYTOMETRY MARKET SHARE, BY PRODUCT & SERVICE (2021) 62
FIGURE 11 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021 62
4.3 FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2022 VS. 2027 63
FIGURE 12 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 63
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64
FIGURE 13 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
FIGURE 14 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
5.2.1 DRIVERS 66
5.2.1.1 Increasing incidence of HIV/AIDS and cancer 66
TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020 66
TABLE 2 CANCER INCIDENCE, 2020 VS. 2040 66
5.2.1.2 Flow cytometry techniques in research activities 67
5.2.1.3 Use of flow cytometry in regenerative medicine 68
5.2.1.4 Growing public−private initiatives in immunology and immuno-oncology research 68
5.2.1.5 Technological advancements in flow cytometry instruments 69
TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS (2019–2022) 69
5.2.2 RESTRAINTS 70
5.2.2.1 High product cost 70
5.2.3 OPPORTUNITIES 71
5.2.3.1 Emerging markets 71
5.2.3.2 Public-private funding initiatives in stem cell research 71
TABLE 4 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA 72
5.2.3.3 Adoption of recombinant DNA technology for antibody production 72
5.2.4 CHALLENGES 72
5.2.4.1 Complexities related to reagent development 72
5.2.4.2 Shortage of well-trained and skilled professionals 73
5.3 PATENT ANALYSIS 73
5.3.1 LIST OF MAJOR PATENTS 74
5.4 SUPPLY CHAIN ANALYSIS 76
FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 77
5.4.1 KEY INFLUENCERS 77
5.5 VALUE CHAIN ANALYSIS 78
FIGURE 16 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 78
5.6 ECOSYSTEM ANALYSIS 79
FIGURE 17 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS 79
5.6.1 ROLE IN ECOSYSTEM 79
5.7 REGULATORY ASSESSMENT 80
5.7.1 STRINGENT FDA REQUIREMENTS 80
5.7.2 ANALYTE-SPECIFIC REAGENT RULE 80
5.7.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 80
5.7.4 ABSENCE OF TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 80
5.7.5 IVD CE MARK APPROVALS 81
5.7.6 US: REIMBURSEMENT SCENARIO 81
5.8 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 5 FLOW CYTOMETRY MARKET- PORTER’S FIVE FORCES ANALYSIS 82
5.8.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 82
5.8.2 BARGAINING POWER OF SUPPLIERS 82
5.8.3 BARGAINING POWER OF BUYERS 83
5.8.4 THREAT OF SUBSTITUTES 83
5.8.5 THREAT OF NEW ENTRANTS 83
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
FIGURE 18 REVENUE SHIFT & NEW REVENUE POCKETS FOR FLOW CYTOMETRY MARKET 84
5.10 KEY CONFERENCES & EVENTS IN 2022-2023 84
TABLE 6 FLOW CYTOMETRY MARKET: DETAILED LIST OF EVENTS AND CONFERENCES 84
5.11 TRADE DATA 85
TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 85
TABLE 8 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 86
5.12 PRICING ANALYSIS 87
TABLE 9 COST OF FLOW CYTOMETERS, BY TYPE 87
TABLE 10 COST OF FLOW CYTOMETERS & OTHER PRODUCTS, BY COMPANY 87
5.12.1 COST OF FLOW CYTOMETRY SOFTWARE 87
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88
FIGURE 19 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND INFLUENCES ON BUYING PROCESSES 88
FIGURE 20 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS 88
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 89
6.1 INTRODUCTION 90
TABLE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90

6.2 CELL-BASED FLOW CYTOMETRY 90
6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET GROWTH 90
TABLE 12 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 91
6.3 BEAD-BASED FLOW CYTOMETRY 91
6.3.1 HIGH RELIABILITY AND MEASUREMENT CONSISTENCIES OF BEAD-BASED FLOW CYTOMETRY TO SUPPORT GROWTH 91
TABLE 13 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 92
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 93
7.1 INTRODUCTION 94
TABLE 14 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 94
7.2 REAGENTS & CONSUMABLES 94
7.2.1 INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET DEMAND 94
TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 95
7.3 INSTRUMENTS 95
7.3.1 LAUNCH OF TECHNOLOGICALLY ADVANCED INSTRUMENTS TO PROPEL MARKET GROWTH 95
TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
7.3.2 CELL ANALYZERS 96
7.3.2.1 Investments by leading market players in developing cell analyzers to drive market growth 96
TABLE 18 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 97
TABLE 19 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 97
7.3.2.2 High-range cell analyzers 98
7.3.2.2.1 Wide adoption of high-range cell analyzers among end users to drive market growth 98
TABLE 20 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 98
7.3.2.3 Mid-range cell analyzers 98
7.3.2.3.1 Availability of compact & high-performance analyzers to support market growth 98
TABLE 21 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
7.3.2.4 Low-range cell analyzers 99
7.3.2.4.1 Low-range analyzers significantly adopted among price-sensitive end users 99
TABLE 22 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
7.3.3 CELL SORTERS 100
TABLE 23 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 100
TABLE 24 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 101
7.3.3.1 High-range cell sorters 101
7.3.3.1.1 High cost and budgetary limitations to restrain market growth 101
TABLE 25 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 101
7.3.3.2 Mid-range cell sorters 102
7.3.3.2.1 Cost-efficiency & frequent product launches for mid-range sorters to drive market growth 102
TABLE 26 MID-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 102
7.3.3.3 Low-range cell sorters 102
7.3.3.3.1 Small-scale labs and research facilities to be major end users of low-range sorters 102
TABLE 27 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
7.4 SERVICES 103
7.4.1 FLOW CYTOMETRY SERVICES TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE 103
TABLE 28 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 103
7.5 SOFTWARE 104
7.5.1 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE TO DRIVE MARKET GROWTH 104
TABLE 29 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 104
7.6 ACCESSORIES 105
7.6.1 PROCEDURAL BENEFITS OFFERED BY FLOW CYTOMETRY ACCESSORIES TO SUPPORT MARKET GROWTH 105
TABLE 30 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 105
8 FLOW CYTOMETRY MARKET, BY APPLICATION 106
8.1 INTRODUCTION 107
TABLE 31 FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
8.2 RESEARCH APPLICATIONS 107
TABLE 32 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 33 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 108

8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY 108
TABLE 34 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY,
BY TYPE, 2020–2027 (USD MILLION) 109
8.2.1.1 Drug discovery 109
8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth 109
TABLE 35 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION) 110
8.2.1.2 Stem cell research 110
8.2.1.2.1 Increasing investments in stem cell research to drive demand for flow cytometry products 110
TABLE 36 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 111
8.2.1.3 In vitro toxicity testing 111
8.2.1.3.1 Growing adoption of flow cytometry in drug discovery & development to support market growth 111
TABLE 37 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2020–2027 (USD MILLION) 112
8.2.2 IMMUNOLOGY 112
8.2.2.1 Growing prevalence of infectious & autoimmune diseases to support market growth 112
TABLE 38 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2020–2027 (USD MILLION) 113
8.2.3 CELL SORTING 113
8.2.3.1 Technologically advanced cell sorters to drive market growth 113
TABLE 39 FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2020–2027 (USD MILLION) 114
8.2.4 APOPTOSIS 114
8.2.4.1 Growing use of apoptosis assays to support market growth 114
TABLE 40 FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2020–2027 (USD MILLION) 114
8.2.5 CELL CYCLE ANALYSIS 115
8.2.5.1 Use of flowcytometry to detect chromosomal abnormalities 115
TABLE 41 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2020–2027 (USD MILLION) 115
8.2.6 CELL VIABILITY 115
8.2.6.1 Growing use of cell viability assays in research to support market growth 115
TABLE 42 FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION) 116
8.2.7 CELL COUNTING 116
8.2.7.1 Flow cytometry permits easy differentiation of cells via scattering or staining 116
TABLE 43 FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION, 2020–2027 (USD MILLION) 117

8.2.8 OTHER RESEARCH APPLICATIONS 117
TABLE 44 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 117
8.3 CLINICAL APPLICATIONS 118
TABLE 45 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 46 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 118
8.3.1 CANCER 119
8.3.1.1 Growing use of flow cytometry techniques in cancer predictions to drive market growth 119
TABLE 47 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040) 119
TABLE 48 FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2020–2027 (USD MILLION) 120
8.3.2 HEMATOLOGY 120
8.3.2.1 Increasing use of flow cytometry in hematology applications to drive market growth 120
TABLE 49 FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2020–2027 (USD MILLION) 120
8.4 IMMUNODEFICIENCY DISEASES 121
8.4.1 BENEFITS OF FLOW CYTOMETRY IN DIAGNOSIS OF IMMUNODEFICIENCY DISEASES TO DRIVE MARKET GROWTH 121
TABLE 50 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES. 121
TABLE 51 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE, BY REGION, 2020–2027 (USD MILLION) 123
8.4.2 ORGAN & TISSUE TRANSPLANTATION 123
8.4.2.1 Increasing organ transplants worldwide to drive market growth 123
TABLE 52 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION, BY REGION, 2020–2027 (USD MILLION) 124
8.4.3 OTHER CLINICAL APPLICATIONS 124
TABLE 53 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 124
8.5 INDUSTRIAL APPLICATIONS 125
8.5.1 GROWING USE OF FLOW CYTOMETRY TECHNIQUES IN FOOD & DIARY TO SUPPORT MARKET GROWTH 125
TABLE 54 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 125
9 FLOW CYTOMETRY MARKET, BY END USER 126
9.1 INTRODUCTION 127
TABLE 55 FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 127
9.2 ACADEMIC & RESEARCH INSTITUTES 127
9.2.1 GROWING COLLABORATIONS AMONG ACADEMIC & RESEARCH INSTITUTES EXPECTED TO DRIVE MARKET 127
TABLE 56 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 128
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 129
9.3.1 USE OF FLOW CYTOMETRY TECHNIQUES IN INFECTIOUS DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH 129
TABLE 57 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 129
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 130
9.4.1 INCREASING INVESTMENTS IN DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 130
TABLE 58 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 130
10 FLOW CYTOMETRY MARKET, BY REGION 131
10.1 INTRODUCTION 132
TABLE 59 FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 132
10.2 NORTH AMERICA 132
FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 133
TABLE 60 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 61 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 134
TABLE 62 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 63 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 64 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 65 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 66 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 67 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 136
TABLE 68 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 136
TABLE 69 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 137
TABLE 70 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10.2.1 US 138
10.2.1.1 High incidence of cancer and HIV-AIDS to drive market growth 138
TABLE 71 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 139
TABLE 72 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139
TABLE 73 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 74 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 75 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 76 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 77 US: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 141
TABLE 78 US: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 141
TABLE 79 US: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 142
TABLE 80 US: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 142
10.2.2 CANADA 143
10.2.2.1 Ongoing government initiatives for life science research to drive demand 143
TABLE 81 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 144
TABLE 82 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 144
TABLE 83 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 84 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 85 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 86 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 87 CANADA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 146
TABLE 88 CANADA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 146
TABLE 89 CANADA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 147
TABLE 90 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 147
10.3 EUROPE 147
TABLE 91 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 92 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 148
TABLE 93 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149
TABLE 94 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 95 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 96 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 97 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 98 EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 151
TABLE 99 EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 151
TABLE 100 EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 152
TABLE 101 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 152
10.3.1 GERMANY 153
10.3.1.1 Strong research & development infrastructure and awareness programs on flow cytometry to ensure market growth 153
TABLE 102 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 153
TABLE 103 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 154
TABLE 104 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 105 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 106 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 107 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 108 GERMANY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 156
TABLE 109 GERMANY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 156
TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 157
TABLE 111 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 157
10.3.2 UK 157
10.3.2.1 Acceptance of flow cytometry products for clinical applications to propel market growth 157
TABLE 112 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 158
TABLE 113 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 114 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 115 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 116 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 117 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 118 UK: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 161
TABLE 119 UK: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 161
TABLE 120 UK: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 162
TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 162
10.3.3 FRANCE 162
10.3.3.1 Strong government funding for proteomics & genomics research to drive market growth 162
TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 163
TABLE 123 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 164
TABLE 124 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 125 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 126 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 127 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 128 FRANCE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 166
TABLE 129 FRANCE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 166
TABLE 130 FRANCE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 167
TABLE 131 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.3.4 ITALY 167
10.3.4.1 Rising geriatric population and increasing activities in life science to drive market growth 167
TABLE 132 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168
TABLE 133 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169
TABLE 134 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 135 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 136 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 137 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 170
TABLE 138 ITALY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 171
TABLE 139 ITALY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 171
TABLE 140 ITALY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 172
TABLE 141 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 172
10.3.5 SPAIN 173
10.3.5.1 Growing focus on cancer diagnosis to drive demand 173
TABLE 142 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 173
TABLE 143 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174
TABLE 144 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 145 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 146 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 147 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 148 SPAIN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 176
TABLE 149 SPAIN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 176
TABLE 150 SPAIN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 177
TABLE 151 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 177
10.3.6 REST OF EUROPE (ROE) 177
TABLE 152 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 178
TABLE 153 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 178
TABLE 154 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 155 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 156 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 157 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 180
TABLE 158 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 180
TABLE 159 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 181
TABLE 160 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 181
TABLE 161 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 182

10.4 ASIA PACIFIC 182
FIGURE 22 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT 183
TABLE 162 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 184
TABLE 163 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 184
TABLE 164 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 185
TABLE 165 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 166 ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 167 ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 168 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 186
TABLE 169 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 187
TABLE 170 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 187
TABLE 171 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 188
TABLE 172 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 188
10.4.1 JAPAN 188
10.4.1.1 Increasing research on flow cytometry-based techniques to drive market growth 188
TABLE 173 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 189
TABLE 174 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 190
TABLE 175 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 176 JAPAN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 177 JAPAN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 178 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 191
TABLE 179 JAPAN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 192
TABLE 180 JAPAN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 192
TABLE 181 JAPAN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 193
TABLE 182 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 193
10.4.2 CHINA 193
10.4.2.1 High incidence of target diseases and growing presence of global players to drive market growth 193
TABLE 183 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 194
TABLE 184 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 194
TABLE 185 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 186 CHINA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 187 CHINA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 188 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 196
TABLE 189 CHINA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 196
TABLE 190 CHINA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 197
TABLE 191 CHINA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 197
TABLE 192 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 198
10.4.3 INDIA 198
10.4.3.1 Rising government funding for research activities in proteomics technologies to drive market growth 198
TABLE 193 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 199
TABLE 194 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 200
TABLE 195 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 196 INDIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 197 INDIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 198 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 201
TABLE 199 INDIA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 201
TABLE 200 INDIA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 202
TABLE 201 INDIA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 202
TABLE 202 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 203
10.4.4 AUSTRALIA 203
10.4.4.1 Uptake of flow cytometry techniques to conduct cancer-related research to support market growth 203
TABLE 203 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 204
TABLE 204 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 204
TABLE 205 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 206 AUSTRALIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 207 AUSTRALIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 208 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 205
TABLE 209 AUSTRALIA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 206
TABLE 210 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 206
TABLE 211 AUSTRALIA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 207
TABLE 212 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 207
10.4.5 SOUTH KOREA 207
10.4.5.1 Increasing awareness initiatives on flow cytometry to support market growth 207
TABLE 213 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 208
TABLE 214 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 208
TABLE 215 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 216 SOUTH KOREA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 217 SOUTH KOREA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 218 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 210
TABLE 219 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 210
TABLE 220 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 211
TABLE 221 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 211
TABLE 222 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 212
10.4.6 SINGAPORE 212
10.4.6.1 Launch of novel technologies for flow cytometry research to support market growth 212
TABLE 223 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 213
TABLE 224 SINGAPORE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 213
TABLE 225 SINGAPORE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 226 SINGAPORE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 227 SINGAPORE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 228 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 215
TABLE 229 SINGAPORE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 215
TABLE 230 SINGAPORE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 216
TABLE 231 SINGAPORE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 216
TABLE 232 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 217
10.4.7 INDONESIA 217
10.4.7.1 Rising prevalence of HIV and cancer to drive demand 217
TABLE 233 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 218
TABLE 234 INDONESIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 218
TABLE 235 INDONESIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 236 INDONESIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 237 INDONESIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 238 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 219
TABLE 239 INDONESIA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 220
TABLE 240 INDONESIA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 220
TABLE 241 INDONESIA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 221
TABLE 242 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 221
10.4.8 REST OF ASIA PACIFIC (ROAPAC) 222
TABLE 243 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 222
TABLE 244 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 223
TABLE 245 REST OF ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 223
TABLE 246 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 223
TABLE 247 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 224
TABLE 248 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 224
TABLE 249 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 225
TABLE 250 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 225
TABLE 251 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 226
TABLE 252 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 226
10.5 LATIN AMERICA 227
TABLE 253 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 227
TABLE 254 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 227
TABLE 255 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 228
TABLE 256 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 228
TABLE 257 LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 228
TABLE 258 LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 259 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 229
TABLE 260 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 230
TABLE 261 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 230
TABLE 262 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 231
TABLE 263 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 231
10.5.1 BRAZIL 232
10.5.1.1 Well-established presence of key market players ensures adoption of flow cytometry products 232
TABLE 264 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 232
TABLE 265 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 233
TABLE 266 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 267 BRAZIL: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 268 BRAZIL: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 269 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 234
TABLE 270 BRAZIL: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 235
TABLE 271 BRAZIL: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 235
TABLE 272 BRAZIL: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 236
TABLE 273 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 236
10.5.2 MEXICO 236
10.5.2.1 Favorable trade agreements to support availability of flow cytometry products 236
TABLE 274 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 237
TABLE 275 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 237
TABLE 276 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 277 MEXICO: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 278 MEXICO: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 279 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 239
TABLE 280 MEXICO: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 239
TABLE 281 MEXICO: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 240
TABLE 282 MEXICO: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 240
TABLE 283 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 241
10.5.3 REST OF LATIN AMERICA (ROLATAM) 241
TABLE 284 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 241
TABLE 285 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 242
TABLE 286 REST OF LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 287 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 288 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 243
TABLE 289 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 243
TABLE 290 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 244
TABLE 291 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 244
TABLE 292 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 245
TABLE 293 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 245
10.6 MIDDLE EAST & AFRICA 246
10.6.1 GROWING RESEARCH COLLABORATIONS AND RISING FUNDING INITIATIVES TO DRIVE MARKET GROWTH 246
TABLE 294 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 246
TABLE 295 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 247
TABLE 296 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 297 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL ANALYZERS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 298 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 299 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 248
TABLE 300 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 249
TABLE 301 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 249
TABLE 302 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 250
TABLE 303 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 250
11 COMPETITIVE LANDSCAPE 251
11.1 INTRODUCTION 251
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 251
TABLE 304 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED 251
11.3 REVENUE ANALYSIS 253
FIGURE 23 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021) 253
11.4 MARKET SHARE ANALYSIS 253
FIGURE 24 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 253
TABLE 305 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION 254
11.5 COMPANY EVALUATION QUADRANT 255
11.5.1 STARS 255
11.5.2 EMERGING LEADERS 255
11.5.3 PERVASIVE PLAYERS 255
11.5.4 PARTICIPANTS 255
FIGURE 25 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 256
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2021) 257
11.6.1 PROGRESSIVE COMPANIES 257
11.6.2 STARTING BLOCKS 257
11.6.3 RESPONSIVE COMPANIES 257
11.6.4 DYNAMIC COMPANIES 257
FIGURE 26 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021 258
11.7 COMPETITIVE BENCHMARKING 259
11.7.1 COMPANY FOOTPRINT 259
TABLE 306 COMPANY PRODUCT FOOTPRINT 260
TABLE 307 COMPANY REGIONAL FOOTPRINT 261
11.8 COMPETITIVE SCENARIO AND TRENDS 262
TABLE 308 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & ENHANCEMENTS (JANUARY 2019-JULY 2022) 262
TABLE 309 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2019–JULY 2022 263
12 COMPANY PROFILES 264
(Business overview, Products offered, Recent Developments, MNM view)*
12.1 KEY PLAYERS 264
12.1.1 BD 264
TABLE 310 BD: BUSINESS OVERVIEW 264
FIGURE 27 BD: COMPANY SNAPSHOT (2021) 265
12.1.2 DANAHER CORPORATION 270
TABLE 311 DANAHER CORPORATION: BUSINESS OVERVIEW 270
FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 271
12.1.3 THERMO FISHER SCIENTIFIC, INC. 276
TABLE 312 THERMO FISHER SCIENTIFIC, INC: BUSINESS OVERVIEW 276
FIGURE 29 THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT (2021) 277
12.1.4 AGILENT TECHNOLOGIES, INC 282
TABLE 313 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 282
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 283
12.1.5 SONY BIOTECHNOLOGY INC. (A SUBSIDIARY OF SONY GROUP CORPORATION) 286
TABLE 314 SONY GROUP CORPORATION: BUSINESS OVERVIEW 286
FIGURE 31 SONY GROUP CORPORATION: COMPANY SNAPSHOT (2021) 287
12.1.6 BIO-RAD LABORATORIES INC. 289
TABLE 315 BIO-RAD LABORATORIES INC: BUSINESS OVERVIEW 289
FIGURE 32 BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT (2021) 290
12.1.7 MILTENYI BIOTEC 293
TABLE 316 MILTENYI BIOTEC: BUSINESS OVERVIEW 293
12.1.8 ENZO BIOCHEM, INC. 296
TABLE 317 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 296
FIGURE 33 ENZO BIOCHEM, INC: COMPANY SNAPSHOT (2021) 297
12.1.9 SYSMEX CORPORATION 299
TABLE 318 SYSMEX CORPORATION.: BUSINESS OVERVIEW 299
FIGURE 34 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021) 300
12.1.10 LUMINEX CORPORATION (A DIASORIN COMPANY) 302
TABLE 319 DIASORIN S.P.A: BUSINESS OVERVIEW 302
FIGURE 35 DIASORIN S.P.A: COMPANY SNAPSHOT (2021) 303
12.1.11 BIOMÉRIEUX SA 305
TABLE 320 BIOMÉRIEUX SA.: BUSINESS OVERVIEW 305
FIGURE 36 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021) 306
12.1.12 CYTONOME/ST, LLC. 307
TABLE 321 CYTONOME/ST, LLC: BUSINESS OVERVIEW 307
12.1.13 SARTORIUS AG 308
TABLE 322 SARTORIUS AG.: BUSINESS OVERVIEW 308
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2021) 309
TABLE 323 SARTORIUS AG: PRODUCT LAUNCHES 310
12.1.14 CYTEK BIOSCIENCES 311
TABLE 324 CYTEK BIOSCIENCES: BUSINESS OVERVIEW 311
FIGURE 38 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2021) 311
12.1.15 UNION BIOMETRICA, INC. 314
TABLE 325 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW 314
12.2 OTHER PLAYERS 315
12.2.1 APOGEE FLOW SYSTEMS LTD. 315
TABLE 326 APOGEE FLOW SYSTEMS LTD: BUSINESS OVERVIEW 315
TABLE 327 APOGEE FLOW SYSTEMS: PRODUCTS & SERVICES OFFERED 315
12.2.2 STRATEDIGM, INC. 316
TABLE 328 STRATEDIGM, INC: BUSINESS OVERVIEW 316
TABLE 329 STRATEDIGM, INC: PRODUCT/SERVICE OFFERINGS 316
TABLE 330 STRATEDIGM: PRODUCT LAUNCHES AND ENHANCEMENTS 317
TABLE 331 STRATEDIGM, INC: DEALS 317
12.2.3 NANOCELLECT BIOMEDICAL, INC. 318
12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD. 319
12.2.5 NEXCELOM BIOSCIENCE LLC. 320
12.2.6 BENNUBIO INC. 320
12.2.7 ORFLO TECHNOLOGIES 321
12.2.8 BAY BIOSCIENCE CO., LTD. 321
12.2.9 CYTOBUOY B.V. 322
12.2.10 BIOLEGEND, INC. 323
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX 324
13.1 DISCUSSION GUIDE 324
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 329
13.3 CUSTOMIZATION OPTIONS 331
13.4 RELATED REPORTS 331
13.5 AUTHOR DETAILS 332

★調査レポート[フローサイトメトリーのグローバル市場予測(~2027):細胞ベース、ビーズベース] ( Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027 / BT6015-22) 販売に関する免責事項
[フローサイトメトリーのグローバル市場予測(~2027):細胞ベース、ビーズベース] ( Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027 / BT6015-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆